User profiles for Alex Horsley

Alex Horsley

University of Manchester
Verified email at nhs.net
Cited by 9778

[HTML][HTML] Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

…, M Toshner, JD Chalmers, LP Ho, A Horsley… - The Lancet …, 2021 - thelancet.com
Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

[HTML][HTML] Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

…, R Borrow, E Linley, S Ahmad, B Parker, A Horsley… - Nature …, 2021 - nature.com
The immune response to SARS-CoV-2 is critical in controlling disease, but there is concern
that waning immunity may predispose to reinfection. We analyzed the magnitude and …

[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

…, AB Docherty, JD Chalmers, LP Ho, A Horsley… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …

[HTML][HTML] Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

…, A Hampshire, JD Chalmers, LP Ho, A Horsley… - Nature medicine, 2023 - nature.com
Post-COVID cognitive deficits, including ‘brain fog’, are clinically complex, with both objective
and subjective components. They are common and debilitating, and can affect the ability to …

Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis

AR Horsley, PM Gustafsson, KA Macleod, C Saunders… - Thorax, 2008 - thorax.bmj.com
Background: Lung clearance index (LCI) is a sensitive marker of early lung disease in children
but has not been assessed in adults. Measurement is hindered by the complexity of the …

[HTML][HTML] Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled …

…, NM Rahman, JA Smith, A Horsley… - The Lancet …, 2021 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries
a substantial risk of severe and prolonged illness; treatment options are currently limited. …

Consensus statement for inert gas washout measurement using multiple-and single-breath tests

PD Robinson, P Latzin, S Verbanck, GL Hall, A Horsley… - 2013 - Eur Respiratory Soc
Inert gas washout tests, performed using the single- or multiple-breath washout technique,
were first described over 60 years ago. As measures of ventilation distribution inhomogeneity, …

[HTML][HTML] Lung clearance index in the assessment of airways disease

A Horsley - Respiratory medicine, 2009 - Elsevier
In the last few years there has been a growing interest in lung clearance index (LCI), a
measure of lung physiology derived from multiple breath washout tests. This resurgence of …

Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post–COVID-19 study

…, M Heightman, TE Hillman, A Horsley… - American journal of …, 2023 - atsjournals.org
Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19)
and lung fibrosis suggest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

AR Horsley, JC Davies, RD Gray, KA Macleod… - Thorax, 2013 - thorax.bmj.com
Background Clinical trials in cystic fibrosis (CF) have been hindered by the paucity of well
characterised and clinically relevant outcome measures. Aim To evaluate a range of …